In the current AML model system, the reduced PTEN protein is associated with increased activation of AKT/mTOR/S6K signaling and proliferation, potentially contributing to a predisposition toward leukemogenesis and reduced survival of the PTEN HET mice. The gene discussed is RPS6KB1; the disease is acute myeloid leukemia.